Previous 10 | Next 10 |
As we mark the halfway point of the year, the economy is in full recovery mode and asset prices are soaring. As we enter the second half of the year though, it is hard to ignore some contradictions. Economic growth in H1 is going to print a big number, and yet, the 10-year Treasury no...
Investment uncertainty is focused on the nature of the current spike in inflation, which the Fed argues is transitory, though a growing number of people do not buy this narrative. Historically, the Fed has never been able to head off any longer-lasting inflation uptrends without a recessi...
Much of last week’s economic focus was on the inflation report. Inflation was indeed pretty hot year over year, but that wasn’t unexpected. With CPI printing at 5% year over year, bond yields fell. But these are small moves, and the trend for rates is still up for now. ...
From a consumer perspective, the consumer is actually now demanding a focus on environmental, social, governance factors. If public expectations for inflation do rise, that is going to be a change from years past. There’s going to be an opportunity to make medical progress ...
Historic efforts to develop COVID-19 vaccines have had two huge effects on the industry. Efforts to waive patents on COVID-19 vaccines to help reduce costs for emerging markets are also stuck. Since healthcare is an industry that has a profound impact on society, there’s a ...
Opportunities and risks in the healthcare sector. The next big areas of innovation in healthcare. Extreme winners and losers in the healthcare sector. For further details see: Building A Healthy Portfolio: Spotlight On Healthcare
The pace of recovery has begun to diverge across economies, with vaccination progress and the scale of government stimulus among the biggest swing factors. Macro disparities have also begun filtering into EPS growth expectations. Cyclically sensitive sectors have dominated the upg...
We still favor above-benchmark strategic allocations to China exposures, and see the recent weakness in Chinese markets offering an attractive entry point. The Federal Reserve made clear its commitment to be well "behind the curve" on inflation and wait to see it to materialize. I...
If two strategies or portfolios are correlated highly enough (higher than 0.84), then their types of risk overlap sufficiently to be part of the same asset class or to serve the same strategic purpose in a portfolio. The demand for acute care has an inelastic demand curve, meaning tha...
I think we're not alone in being quite amazed by the resilience that the US market has shown following the very violent selloff in February and March. One of our big themes, digital innovation, continues to lead, transforming what I would call the more traditional or, sort of, classic...
News, Short Squeeze, Breakout and More Instantly...
KraneShares Trust Emerging Markets Healthcare Index Company Name:
KMED Stock Symbol:
NYSE Market:
NEW YORK , Oct. 23, 2019 /PRNewswire/ -- Krane Funds Advisors, LLC, ("KraneShares"), a leading provider of China -focused ETFs, has partnered with acclaimed technical analysis and research provider, Nasdaq Dorsey Wright to launch the KraneShares China Rotation Model, designed to provide ...